TDC
ARRY

Thompson Davis & Co’s Array Biopharma Inc ARRY Stock Holding History

Thompson Davis & Co’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$2K Hold
125
– – ﹤0.01% 682
2018
Q2 		$2K Hold
125
– – ﹤0.01% 633
2018
Q1 		$2K Buy
+125
New +$2K 0.01% 587
2014
Q4 		– Sell
-1,000
Closed -$4K – 1314
2014
Q3 		$4K Buy
+1,000
New +$3.94K 0.01% 967

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Thompson Davis & Co's ARRY Position: Q3 2018 in Review

Thompson Davis & Co held its Array Biopharma Inc (ARRY) position steady in Q3 2018 at 125 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #682.

Thompson Davis & Co first reported a position in ARRY in Q3 2014 and has held it in 4 quarters since. The position peaked at $4K in Q3 2014. 208 funds tracked by Wall St. Rank hold ARRY as of Q3 2018.

  • Thompson Davis & Co held 125 shares of Array Biopharma Inc worth $2K as of Q3 2018.
  • Thompson Davis & Co left its Array Biopharma Inc share count unchanged in Q3 2018.
  • Array Biopharma Inc made up ﹤0.01% of Thompson Davis & Co's portfolio in Q3 2018, its #682 holding.
  • Thompson Davis & Co first reported a position in Array Biopharma Inc in Q3 2014 and has held it in 4 quarters since.
  • Thompson Davis & Co's Array Biopharma Inc position peaked at $4K in Q3 2014.
  • 208 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.